Application 219757
- Type
- NDA
- Sponsor
- ROSEMONT PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VOSTALLY | RAMIPRIL | SOLUTION;ORAL | 1MG/ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N219757-001 | VOSTALLY | RAMIPRIL | 1MG/ML | SOLUTION / ORAL | RLD | 2025-07-23 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N219757-001 | VOSTALLY | 1MG/ML | SOLUTION / ORAL | RLD | 2025-07-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N219757-001 | VOSTALLY | 1MG/ML | SOLUTION / ORAL | RLD | 2025-07-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219757-001 | VOSTALLY | 1MG/ML | SOLUTION / ORAL | RLD, RS | 2025-07-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219757-001 | VOSTALLY | 1MG/ML | SOLUTION / ORAL | RLD, RS | 2025-07-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219757-001 | VOSTALLY | 1MG/ML | SOLUTION / ORAL | RLD, RS | 2025-07-23 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219757-001 | VOSTALLY | 1MG/ML | SOLUTION / ORAL | RLD | 2025-07-23 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219757-001 | 12343338 | 2039-08-16 | U-4233 | Drug product | 2025-07-30 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ramipril | RAMIPRIL | Northwind Health Company, LLC | ab09a67e-18fe-c860-e053-2a95a90a4d03 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Northwind Health Company, LLC | ab324cb3-2aaa-b57f-e053-2995a90a2055 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Northwind Health Company, LLC | fb0892da-3db7-3202-e053-6394a90ab605 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | A-S Medication Solutions | 5fb23b7d-ed2b-4984-89c8-d0a509b917e1 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | GSMS, Incorporated | 62f6aa5a-7587-4349-b61d-b2c235749979 | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | A-S Medication Solutions | 1576188e-efd4-4e14-870e-fd9bd2751c45 | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | A-S Medication Solutions | dd3162eb-5f09-47ac-9efd-3ddeee695a25 | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Zydus Lifesciences Limited | 496b346b-ca79-4483-a950-bed9464e6a9d | 2024-12-04 | RAMIPRIL | |
| Ramipril | RAMIPRIL | A-S Medication Solutions | 4a91b706-c614-4472-92f2-4da5d7bdbf27 | 2024-11-21 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Proficient Rx LP | 01da05d8-e72e-4208-bf92-a5cd929f15ab | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Exelan Pharmaceuticals, Inc. | 1e1dfacf-b831-4743-a874-9a5e5ef8a120 | 2021-10-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Proficient Rx LP | 33bdfe96-1b7a-4859-b1c9-ef94b8bb7a2a | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Proficient Rx LP | afd766bc-2a42-40b5-b33f-1a8b5ce2622e | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Proficient Rx LP | 543914e5-c164-4fc7-8007-9fab2b13dda7 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
| Ramipril | RAMIPRIL | Proficient Rx LP | d3513b8b-2d8a-456d-b942-a25ec1965b04 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | RAMIPRIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.